Erythroid hypoplasia

Erythroid hypoplasia: Description, Causes and Risk Factors:Erythroid hypoplasia is a condition in which an abnormally low number of red blood cells are produced and released into the body. There are a number of different conditions that can cause this disorder, some of them congenital and some of them caused by disease or injury. Patients with this condition may have moderate-to-severe anemia and can be at risk from lack of oxygen in the blood and cells. Blood transfusions are often used to treat this disorder in an emergency. In some patients, erythroid hypoplasia may need to be treated long term through the use of blood transfusions while in other cases the disorder may correct on its own or with the assistance of medication.Erythroid hypoplasia is a rare disorder characterized by a profound reduction in erythroblasts in the bone marrow. It can be a congenital disorder or can be acquired in association with an underlying disease. In the acquired group, the most common disease associations are with thymoma, viral infections, connective tissue diseases, and malignancy. Occasional reports have documented the occurrence of erythroid hypoplasia in patients with myelodysplastic syndrome (MDS). These patients present with severe anemia, reticulocytopenia, and a paucity of recognizable erythroid cells in the bone marrow, associated with some evidence of an intrinsic cell defect. In addition to erythroid hypoplasia, bilineage or trilineage dysplasia in a high percentage of cells (> 20%) is a crucial determinant for the recognition of this entity.The exact prevalence of erythroid hypoplasia in MDS is not known. In a series of 360 cases of MDS diagnosed in a single institute over a 10 year period, six (prevalence of 1.6%) were found to have MDS with erythroid hypoplasia/aplasia. In a review of the literature only 16 well documented cases of MDS with erythroid hypoplasia/aplasia. In that review, there was a male predominance (male to female ratio of 3:1), with a mean age of 70 years (range, 41-87). There were no pediatric cases in their series.A 54-year-old woman was admitted due to high-grade fever, cervical lymphadenopathy and general malaise. On examination, severe anemia was noted, direct Coombs and cold hemagglutinin tests were positive and the haptoglobin level was low in the peripheral blood. However, a bone marrow examination revealed marked erythroid hypoplasia. A diagnosis was made of co-existing combined type autoimmune hemolytic anemia (AIHA) and erythroid hypoplasia. A pathologic diagnosis of de novo CD5-positive diffuse large B-cell lymphoma (de novo CD5'+' DLBCL) was made based on a cervical lymph node biopsy. The patient was treated with CHOP accompanied by rituximab (R-CHOP), resulting in complete remission after 3 courses of chemotherapy. The AIHA and erythroid hypoplasia subsided after 2 courses of R-CHOP. The sera obtained during erythroid hypoplasia significantly inhibited the growth of erythroid progenitor cells (erythroid colony-forming units, CFU-E) from her bone marrow collected after recovery.Symptoms:erythroid hypoplasiaThe symptoms of erythroid hypoplasia are the same as those experienced with other types of anemia. Unexplained fatigue is the most common symptom because the decrease in oxygen in the blood makes it difficult for the body and brain to receive enough oxygen. Feelings of being out of breath are also commonly experienced with erythroid hypoplasia as are feelings of dizziness or faintness. Patients with low red blood cell counts may also appear pale.Diagnosis:The first step in the diagnosis of erythroid hypoplasia is detection with reliable, accurate tests so that important clues to underlying disease are not overlooked and patients are not subjected to unnecessary tests for and treatment.Tests:CBC.
  • Bone marrow examination.
Treatment:Patients with severe erythroid hypoplasia may require emergency medical attention. A severe drop in the number of red blood cells in a patient's bloodstream may cause the patient to lose consciousness and suffer brain damage. An emergency transfusion can provide relief from the symptoms of severe anemia. In some cases, however, patients may have sustained irreversible damage to the hematopoietic stem cells, in which case blood or marrow treatments may be needed frequently in order to keep the patient from showing symptoms of erythroid hypoplasia. In other cases, medication that stimulates red blood cell production may be enough to correct the disorder.NOTE: The above information is educational purpose. The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition.DISCLAIMER: This information should not substitute for seeking responsible, professional medical care.


  1. Himangshu Barman

    Respected Sir/Madam
    I am sending some findings of a patient who is my relative.
    M:E ratio 1:1
    Erythroid: Erythropoiesis-Normoblastic maturation, mild erythroid hyperplasia
    Normocellular bone marrow with trilineage haematopoeisis. Erythroid hyperplasia noted with megaloblastic maturation.
    Megakarocyte are seen.
    Subtle diffuse intersistial increase in atypical cells with distinct cell membrane and abundant clear cytoplasm noted.

    Please in form me whether the patient is curaeable for he may develop leukomea in near future. Patient is maale in sex with 42 years and his father died 2 years ago in leukomea

    • maisteri

      It is not possible to predict whether a person will develop leukaemia or not at some point in the future. So far there are no signs of malignancy. Atypical cells may be present in a healthy person, this doesn’t mean that a person will develop blood cancer. Although megaloblasts are suggestive of B12-deficiency and pernicious anaemia which is curable.


Submit a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prolonged Exposure to Blue Light May Affect Longevity

Prolonged Exposure to Blue Light May Affect Longevity

A new study from Oregon State University suggests that daily exposure to blue light, emitted from phones, computers, and other gadgets, may affect longevity damaging cells in the brain, as well as retinas. For the research, the scientists exposed flies to blue LED...

Long-term Study: People Who Walk Slowly May Age Faster

Long-term Study: People Who Walk Slowly May Age Faster

According to a new long-term study, which followed more than 900 people from New Zealand for around 40 years, people in their 40s who walk slowly are more likely to show symptoms of accelerated biological aging and compromised brain integrity. Within the scope of the...

[WpProQuiz 1]

Featured Products

[recent_products per_page="6" orderby="menu_order" columns="6" order="ASC"]
Kangoo Jumps Training: 5 Beginner Exercises

Kangoo Jumps Training: 5 Beginner Exercises

In childhood, many of us dreamed of learning to jump high. Now, after years, it became easier - Kangoo Jumps has appeared. This is one of the relatively new, but quickly gaining popularity types of fitness training. There are several advantages of jumpers. ...

read more